There's a big difference between honest, evidence-based recommendations and paid promotion, and unfortunately, the two aren't always easy to tell apart
The therapeutic effect targets substantial body weight reduction while managing underlying cardiometabolic risk markers [1, 2]
Others improve gut health, which indirectly enhances hormone function
Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety
Extended-release exenatide (Bydureon BCise) has an apparent terminal half-life of approximately 2 weeks due to its depot formulation, with drug concentrations potentially persisting for 8-10 weeks after discontinuation
Slechts 43% haalde minstens 1,2 g/kg per dag, 10% minstens 1,6 g/kg en 5% minstens 2,0 g/kg